Literature DB >> 11352748

Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase.

M P Patricelli1, B F Cravatt.   

Abstract

Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that catabolizes several neuromodulatory fatty acid amides, including the endogenous cannabinoid anandamide and the sleep-inducing lipid oleamide. FAAH belongs to a large group of hydrolytic enzymes termed the amidase signature (AS) family that is defined by a conserved, linear AS sequence of approximately 130 amino acids. Members of the AS family display strikingly different substrate selectivities, yet the primary structural regions responsible for defining substrate recognition in these enzymes remain unknown. In this study, a series of unbranched p-nitroanilide (pNA) substrates ranging from 6 to 20 carbons in length was used to probe the acyl chain binding specificity of FAAH, revealing that this enzyme exhibits a strong preference for acyl chains 9 carbons in length or longer. A fluorophosphonate inhibitor of FAAH containing a photoactivatable benzophenone group was synthesized and used to locate a region of the enzyme implicated in substrate binding. Protease digestion and mass spectrometry analysis of FAAH-inhibitor conjugates identified the major site of cross-linking as residues 487-493. Site-directed mutagenesis revealed that a single residue in this region, I491, strongly influenced substrate specificity of FAAH. For example, an I491A mutant displayed a greatly reduced binding affinity for medium-chain pNA substrates (7-12 carbons) but maintained nearly wild-type binding and catalytic constants for longer chain substrates (14-20 carbons). Mutation of I491 to aromatic or more polar residues generated enzymes with relative hydrolytic efficiencies for medium- versus long-chain pNAs that varied up to 90-fold. Collectively, these studies indicate that I491 participates in hydrophobic binding interactions with medium-chain FAAH substrates. Additionally, the significant changes in substrate selectivity achieved by single amino acid changes suggest that FAAH possesses a rather malleable substrate binding domain and may serve, along with other AS enzymes, as a template for the engineering of amidases with novel and/or tailored specificities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352748     DOI: 10.1021/bi002578r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Activity-based probes for the proteomic profiling of metalloproteases.

Authors:  Alan Saghatelian; Nadim Jessani; Arul Joseph; Mark Humphrey; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

2.  Clickable, photoreactive inhibitors to probe the active site microenvironment of fatty acid amide hydrolase().

Authors:  Susanna M Saario; Michele K McKinney; Anna E Speers; Chu Wang; Benjamin F Cravatt
Journal:  Chem Sci       Date:  2011-08-11       Impact factor: 9.825

3.  Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.

Authors:  Amy K Dickason-Chesterfield; Stephanie R Kidd; Steven A Moore; John M Schaus; Bin Liu; George G Nomikos; Christian C Felder
Journal:  Cell Mol Neurobiol       Date:  2006-05-31       Impact factor: 5.046

4.  Development of highly sensitive fluorescent assays for fatty acid amide hydrolase.

Authors:  Huazhang Huang; Kosuke Nishi; Hsing-Ju Tsai; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-12-20       Impact factor: 3.365

Review 5.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

6.  Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.

Authors:  Jessica P Alexander; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2005-11

7.  Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse.

Authors:  Dollada Srisai; Matthew P Gillum; Brandon L Panaro; Xian-Man Zhang; Naiphinich Kotchabhakdi; Gerald I Shulman; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

Review 8.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

9.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 10.  Measuring endocannabinoid hydrolysis: refining our tools and understanding.

Authors:  William Marrs; Nephi Stella
Journal:  AAPS J       Date:  2009-05-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.